药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02269 药明生物

未开盘 01-21 16:08:06

18.200

-0.500

-2.67%

最高19.100	最低18.000	成交量4,797万
今开18.880	昨收18.700	日振幅5.88%
总市值747.29亿	流通市值747.29亿	总股本41.06亿
成交额8.80亿	换手率1.17%	流通股本41.06亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":18.2,"timestamp":1737446886015,"preClose":18.7,"halted":0,"volume":47967862,"delay":0,"floatShares":4106000000,"shares":4106000000,"eps":0.8733609878304038,"marketStatus":"未开盘","change":-0.5,"latestTime":"01-21 16:08:06","open":18.88,"high":19.1,"low":18,"amount":880239250,"amplitude":0.058824,"askPrice":18.2,"askSize":172500,"bidPrice":18.18,"bidSize":128500,"shortable":3,"etf":0,"ttmEps":0.6416293526148292,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1737509400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":18.7,"openAndCloseTimeList":[[1737423000000,1737432000000],[1737435600000,1737446400000]],"volumeRatio":0.96513,"optionData":{"bulkOrders":[{"symbol":"WXB.HK","call":true,"expireDate":1737907200000,"strike":"20.00","timestamp":1737423811267,"price":0.18,"volume":210,"amount":18900,"type":"*"}]},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.5511,"impliedVolPercentile":0.1579},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2505217496","title":"药明生物01月21日主力净流出5465万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2505217496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505217496?lang=zh_cn&edition=full","pubTime":"2025-01-21 16:15","pubTimestamp":1737447328,"startTime":"0","endTime":"0","summary":"01月21日, 药明生物股价跌2.67%，报收18.20元，成交金额8.80亿元，换手率1.17%，振幅5.88%，量比0.96。药明生物今日主力资金净流出5465万元，上一交易日主力净流入1.01亿元。该股近5个交易日上涨4.32%，主力资金累计净流入5722万元；近20日主力资金累计净流出8615万元，其中净流出天数为13日。该股主力净额占比0.07%，港股市场排名2610/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121161546abb2dad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121161546abb2dad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348825331.USD","BK1141","LU0051755006.USD","LU0320764599.SGD","LU0359202008.SGD","LU0417516738.SGD","LU0039217434.USD","LU0819121731.USD","LU0326950275.SGD","LU0181495838.USD","LU0516423091.SGD","LU0823426308.USD","LU1720050803.USD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0516422952.EUR","LU1242518931.SGD","LU0823426480.USD","SG9999002463.SGD","LU1794554557.SGD","02269","BK1521","LU0572944931.SGD","LU0043850808.USD","LU0516423174.USD","BK1576","LU0979878070.USD","LU1242518857.USD","LU1688375341.USD","BK1610","LU0140636845.USD","LU0456846285.SGD","LU0327786744.USD","LU1880383366.USD","LU0856984785.SGD","LU2039709279.SGD","LU0417516902.SGD","LU0516422440.USD","BK1589","LU0052750758.USD","LU0359201612.USD","LU0456827905.SGD","LU0516422366.SGD","SG9999002562.SGD","LU0588546209.SGD","LU0348735423.USD","LU0307460666.USD"],"gpt_icon":0},{"id":"2505296174","title":"港股三大指数探底回升 恒指半日涨1.12% 中芯国际(00981)涨7.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505296174","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505296174?lang=zh_cn&edition=full","pubTime":"2025-01-21 12:12","pubTimestamp":1737432743,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数探底回升，截至午间收盘，恒指涨1.12%，国企指涨1.32%，恒科指涨2.49%。碧桂园公布，已达成复牌指引下的要求。其两大主要品牌的同店销售恶化到同比减少24.6%和18.5%；旗下品牌\"怂火锅\"同店销售减少同比收窄至26.9%，主要原因是门店网络的改善。中泰国际表示，受惠去年四季度政策组合拳发力，中国四季度GDP同比增长5.4%，全年保“5”达成。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/ZTI4OWYyMGNkOTYzNTgwNWE4Mjg2ODY4MjM2ODAzNjMx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZTI4OWYyMGNkOTYzNTgwNWE4Mjg2ODY4MjM2ODAzNjMx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1951854","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02015","LU0516423174.USD","LU2039709279.SGD","LU0320764599.SGD","HSI","688981","BK1103","LU0348825331.USD","LU0819121731.USD","LU0516422366.SGD","LU0456827905.SGD","LU2148510915.USD","MHImain","HSTECH","LU0140636845.USD","LU0516422440.USD","LU0572944931.SGD","02269","YANG","LI","LU0516422952.EUR","00881","SG9999002463.SGD","MCHmain","LU0287142896.SGD","LU1242518857.USD","00981","513600","BK1610","00316","BK1587","BK1133","LU0979878070.USD","BK0214","LU1880383366.USD","LU0708995583.HKD","LU1064131003.USD","HSImain","02833","LU0856984785.SGD","00762","BK1589","HHImain","HSCEI","LU0456846285.SGD","BK1536","BK1239","LU0039217434.USD","LU0173614495.USD"],"gpt_icon":1},{"id":"2505260840","title":"药明生物(02269)下跌2.03%，报18.32元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2505260840","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505260840?lang=zh_cn&edition=full","pubTime":"2025-01-21 10:53","pubTimestamp":1737428018,"startTime":"0","endTime":"0","summary":"1月21日，药明生物(02269)盘中下跌2.03%，截至10:53，报18.32元/股，成交3.08亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商，提供全面、综合及高度定制的服务，包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额，已与全球20大制药公司中的12家建立合作关系。截至2024年中报，药明生物营业总收入85.74亿元、净利润14.99亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/21105347639751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1242518857.USD","IE00B0JY6N72.USD","LU0348735423.USD","LU0326950275.SGD","LU0348825331.USD","LU1720050803.USD","LU1794554557.SGD","BK1521","BK1141","LU0052750758.USD","LU0516422952.EUR","LU0039217434.USD","LU0572944931.SGD","LU1688375341.USD","LU0307460666.USD","LU0456827905.SGD","LU0516423174.USD","LU0140636845.USD","LU0417516738.SGD","SG9999002562.SGD","LU0043850808.USD","LU0181495838.USD","LU0417516902.SGD","LU0320764599.SGD","LU0327786744.USD","02269","BK1610","LU0979878070.USD","LU0588546209.SGD","LU0456846285.SGD","LU0516422366.SGD","LU0823426480.USD","LU0856984785.SGD","LU1880383366.USD","SG9999002463.SGD","BK1576","BK1589","LU0359201612.USD","LU0051755006.USD","LU0708995583.HKD","LU0359202008.SGD","LU1242518931.SGD","LU0819121731.USD","LU0516423091.SGD","LU2039709279.SGD","LU0516422440.USD","LU0823426308.USD"],"gpt_icon":0},{"id":"2505269290","title":"【特约大V】邓声兴：内地发布2025年汽车以旧换新政策细则 汽车股有利","url":"https://stock-news.laohu8.com/highlight/detail?id=2505269290","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505269290?lang=zh_cn&edition=full","pubTime":"2025-01-21 09:49","pubTimestamp":1737424196,"startTime":"0","endTime":"0","summary":"国指升126点或1.8%，收7,235点；恒生科技指数升116点或2.6%，收4,595点。内地发布2025年汽车以旧换新政策细则，车股蔚来 、比亚迪 及小鹏 升4%至4.4%，理想 升3%。内地发布2025年汽车以旧换新政策细则，汽车股有利。此外，基于现有合同预期，2025年将有24个PPQ项目。同时，爱尔兰生产设施亦将按计划预期于2025年产生利润。对集团2024年实现预期收入增长充满信心，并预期2025年收入将较去年实现加速增长。目标价$23，止蚀价$15.1。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/NDMwYzk0ZmE3ODZlM2UzYjdhOWIyNjc2MTkzNTM0OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NDMwYzk0ZmE3ODZlM2UzYjdhOWIyNjc2MTkzNTM0OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1951828","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","BK4232","IE00B0JY6N72.USD","LU0320764599.SGD","LU0516423174.USD","LU1720050803.USD","LU0348825331.USD","LU0819121731.USD","LU0823426480.USD","LU0516422366.SGD","BK1576","LU0456827905.SGD","LU1794554557.SGD","LU0516423091.SGD","BK1141","LU0140636845.USD","LU0051755006.USD","LU0516422440.USD","LU0572944931.SGD","02269","LU0326950275.SGD","LU0043850808.USD","BK1249","LU0516422952.EUR","LU0359202008.SGD","LU0588546209.SGD","R","SG9999002562.SGD","SG9999002463.SGD","LU0417516738.SGD","LU0327786744.USD","LU1242518857.USD","BK1610","LU1242518931.SGD","BK4022","LU0979878070.USD","BK1246","LU1880383366.USD","09896","LU0708995583.HKD","LU0823426308.USD","LU0181495838.USD","LU0856984785.SGD","LU1688375341.USD","BK1589","LU0359201612.USD","LU0456846285.SGD","LU2039709279.SGD","LU0052750758.USD","LU0039217434.USD"],"gpt_icon":0},{"id":"2505026496","title":"南向资金1月20日净买入药明生物122.30万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2505026496","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505026496?lang=zh_cn&edition=full","pubTime":"2025-01-21 09:30","pubTimestamp":1737423023,"startTime":"0","endTime":"0","summary":"1月20日, 南向资金增持药明生物122.30万股，连续3日增持。截止当日收盘，港股通共持有药明生物113112.06万股，占流通股27.54%。药明生物近5个交易日上涨10.65%，港股通累计减持427.86万股；近20个交易日上涨8.09%，港股通累计减持1373.14万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121093141abb275b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121093141abb275b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0327786744.USD","LU0052750758.USD","LU2039709279.SGD","LU0348735423.USD","LU0856984785.SGD","LU0516422366.SGD","LU1720050803.USD","BK1521","LU0043850808.USD","LU0140636845.USD","LU0516422952.EUR","LU0359201612.USD","LU0516423091.SGD","LU0979878070.USD","02269","LU0823426308.USD","LU0708995583.HKD","LU0417516738.SGD","LU0181495838.USD","LU1880383366.USD","BK1576","LU0516422440.USD","LU0039217434.USD","SG9999002562.SGD","LU0320764599.SGD","LU0051755006.USD","BK1141","LU1242518857.USD","LU0588546209.SGD","LU0823426480.USD","BK1610","BK1589","LU0307460666.USD","LU1794554557.SGD","LU0572944931.SGD","LU0456846285.SGD","LU1242518931.SGD","LU0348825331.USD","LU0359202008.SGD","LU0417516902.SGD","LU0819121731.USD","SG9999002463.SGD","IE00B0JY6N72.USD","LU0456827905.SGD","LU1688375341.USD","LU0326950275.SGD","LU0516423174.USD"],"gpt_icon":0},{"id":"2504947487","title":"药明生物01月20日获主力大幅加仓1.01亿元 环比增加117.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504947487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504947487?lang=zh_cn&edition=full","pubTime":"2025-01-20 16:16","pubTimestamp":1737360996,"startTime":"0","endTime":"0","summary":"01月20日, 药明生物股价涨4.12%，报收18.70元，成交金额11.02亿元，换手率1.42%，振幅5.35%，量比1.30。药明生物今日主力资金净流入1.01亿元，连续3日净流入，上一交易日主力净流入4649万元，今日环比增加117.10%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为85.71%，平均涨幅为3.77%。该股近5个交易日上涨9.70%，主力资金累计净流入1.76亿元；近20日主力资金累计净流出4818万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120161659a2288e61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120161659a2288e61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0307460666.USD","LU0417516902.SGD","LU0051755006.USD","LU1242518931.SGD","LU0516423174.USD","LU0823426308.USD","LU1794554557.SGD","LU0043850808.USD","BK1521","LU0348825331.USD","LU0456846285.SGD","LU0979878070.USD","BK1610","LU1242518857.USD","BK1589","LU0327786744.USD","LU0320764599.SGD","LU0326950275.SGD","LU1688375341.USD","LU1880383366.USD","LU0359202008.SGD","02269","LU0052750758.USD","LU2039709279.SGD","LU0456827905.SGD","LU0348735423.USD","BK1141","LU0588546209.SGD","LU0823426480.USD","BK1576","LU0359201612.USD","LU0516422366.SGD","LU0516423091.SGD","IE00B0JY6N72.USD","LU0572944931.SGD","LU0819121731.USD","SG9999002562.SGD","SG9999002463.SGD","LU0039217434.USD","LU1720050803.USD","LU0516422440.USD","LU0708995583.HKD","LU0181495838.USD","LU0516422952.EUR","LU0140636845.USD","LU0856984785.SGD","LU0417516738.SGD"],"gpt_icon":0},{"id":"2504251534","title":"招银国际：维持药明生物(02269)“买入”评级 目标价上调至24.24港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504251534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504251534?lang=zh_cn&edition=full","pubTime":"2025-01-20 14:08","pubTimestamp":1737353339,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研究报告称，维持药明生物“买入”评级，目标价由22.88港元上调至24.24港元，以反映需求恢复，且认为需求为今年带来良好展望，预测其2024至2026年的收入同比增长7.1%、13.4%及15.6%，经调整净利润同比升0.9%、13%及15.6%。该行提及，药明生物去年完成工艺性能确认项目77个，同比增长26%，并预期今年将同比增长31%至101个项目。该行估计相关势头对公司CMO收入的未来增长有利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02269"],"gpt_icon":0},{"id":"2504423217","title":"药明生物：去年新增项目创新高 评级买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2504423217","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504423217?lang=zh_cn&edition=full","pubTime":"2025-01-20 11:45","pubTimestamp":1737344745,"startTime":"0","endTime":"0","summary":"药明生物去年新增 151 个项目创新高，赋能 7 个分子研究服务全球项目，近期有权收取约 1.4 亿美元款项。海外业务稳步推进，爱尔兰生产设施有望今年收支平衡。管理层重申去年指引，预期收入及经调整盈利均增长 5%至 10%，对今年收入增长加速有信心。去年完成工艺性能确认项目 77 个，按年增长 26%，预计今年增长 31%至 101 个项目，这对公司 CMO 收入未来增长有利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120121707986c4462&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120121707986c4462&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02269"],"gpt_icon":0},{"id":"2504449390","title":"大行评级｜招银国际：上调药明生物目标价至24.24港元 需求为今年带来良好展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449390","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504449390?lang=zh_cn&edition=full","pubTime":"2025-01-20 11:07","pubTimestamp":1737342474,"startTime":"0","endTime":"0","summary":"招银国际发表报告指出，药明生物去年新增151个项目，创新高。该行提及，药明生物去年完成工艺性能确认项目77个，按年增长26%，并预期今年将按年增长31%至101个项目。该行料相关势头对公司CMO收入的未来增长有利。招银国际维持对药明生物的“买入”评级，目标价由22.88港元上调至24.24港元，以反映需求恢复，且认为需求为今年带来良好展望，预测其2024至2026年的收入按年增长7.1%、13.4%及15.6%，经调整净利润按年升0.9%、13%及15.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/20110747599115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02269"],"gpt_icon":0},{"id":"2504144631","title":"【港股异动 | 药明生物(02269.HK)涨超5% 】药明生物(02269.HK)涨超5%，截至发稿，涨5.01%，报18.86港元，成交额6.09亿港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2504144631","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504144631?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:54","pubTimestamp":1737341659,"startTime":"0","endTime":"0","summary":"药明生物(02269.HK)涨超5%，截至发稿，涨5.01%，报18.86港元，成交额6.09亿港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/20105447598858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0588546209.SGD","LU0417516902.SGD","LU0516422440.USD","LU0856984785.SGD","LU0572944931.SGD","BK1589","LU1880383366.USD","LU0039217434.USD","LU0140636845.USD","LU0456827905.SGD","LU0516422952.EUR","LU1794554557.SGD","LU0052750758.USD","SG9999002562.SGD","LU0417516738.SGD","LU0979878070.USD","LU0348825331.USD","LU0456846285.SGD","LU0043850808.USD","LU1688375341.USD","LU0823426308.USD","LU0819121731.USD","LU1242518931.SGD","SG9999002463.SGD","LU0320764599.SGD","LU0327786744.USD","LU0823426480.USD","LU0307460666.USD","LU1242518857.USD","LU0181495838.USD","BK1141","LU0051755006.USD","LU0516422366.SGD","LU2039709279.SGD","LU0516423091.SGD","LU0708995583.HKD","LU1720050803.USD","LU0326950275.SGD","LU0359201612.USD","BK1521","LU0359202008.SGD","LU0516423174.USD","BK1576","IE00B0JY6N72.USD","LU0348735423.USD","02269","BK1610"],"gpt_icon":0},{"id":"2504257445","title":"港股异动 | 药明生物(02269)涨超5% 新签项目数量强劲增长 公司预计2025年业务势头呈现加速态势","url":"https://stock-news.laohu8.com/highlight/detail?id=2504257445","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504257445?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:48","pubTimestamp":1737341304,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明生物涨超5%，截至发稿，涨5.01%，报18.86港元，成交额6.09亿港元。公司维持2024年指引不变，包括5%至10%收入增长，8%至14%扣新冠收入增长；并预计2025年业务势头呈现加速态势。另外，营运效率提升，管理层预计2025年利润率提升100至150个基点。此外，报告指出，由于公司新签项目数量强劲增长，PPQ项目储备丰富有望放量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 药明生物(02269)涨超5% 新签项目数量强劲增长 公司预计2025年业务势头呈现加速态势","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348825331.USD","LU0359202008.SGD","LU0456827905.SGD","LU0708995583.HKD","LU1720050803.USD","IE00B0JY6N72.USD","LU0140636845.USD","LU0819121731.USD","BK1141","LU0327786744.USD","LU0823426308.USD","LU0348735423.USD","LU0320764599.SGD","LU1880383366.USD","LU0979878070.USD","LU1688375341.USD","BK1589","LU0516422366.SGD","BK1610","LU0326950275.SGD","LU2039709279.SGD","LU0417516902.SGD","LU0572944931.SGD","LU0181495838.USD","LU0359201612.USD","LU0043850808.USD","LU0456846285.SGD","LU0516423091.SGD","02269","BK1576","LU0052750758.USD","LU0516423174.USD","BK1521","LU0823426480.USD","LU0417516738.SGD","LU1794554557.SGD","LU0588546209.SGD","LU0039217434.USD","SG9999002562.SGD","LU1242518931.SGD","LU0051755006.USD","LU0856984785.SGD","LU0516422440.USD","LU0307460666.USD","SG9999002463.SGD","LU1242518857.USD","LU0516422952.EUR"],"gpt_icon":0},{"id":"2504467604","title":"《大行》招银国际升药明生物(02269.HK)目标价至24.24元 需求为今年带来良好展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2504467604","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504467604?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:35","pubTimestamp":1737340500,"startTime":"0","endTime":"0","summary":"招银国际发表报告指出，药明生物去年新增151个项目，创新高。该行提及，药明生物去年完成工艺性能确认项目77个，按年增长26%，并预期今年将按年增长31%至101个项目。该行料相关势头对公司CMO收入的未来增长有利。招银国际维持对药明生物的“买入”评级，目标价由22.88元上调至24.24元，以反映需求恢复，且认为需求为今年带来良好展望，预测其2024至2026年的收入按年增长7.1%、13.4%及15.6%，经调整净利润按年升0.9%、13%及15.6%。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190319115856757_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190319115856757_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1411682/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02269"],"gpt_icon":0},{"id":"1101129739","title":"异动解读 | 医药股集体走强 医保丙类目录利好预期推动药明生物股价大涨6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1101129739","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101129739?lang=zh_cn&edition=full","pubTime":"2025-01-20 09:58","pubTimestamp":1737338304,"startTime":"0","endTime":"0","summary":"港股医药股今日集体走强,大涨概念股中,备受瞩目的药明生物(02269.HK)盘中大涨6.35%。\n\n推动药明生物股价大涨的主要原因包括两个方面:一是整体医药股受到市场追捧,带动行业板块集体上涨;二是市场对即将出台的医保丙类目录存在较高预期,有望为国内创新药企如药明生物等打开更广阔的市场空间。\n\n根据国家医保局负责人表示,医保丙类目录将于今年内发布,聚焦那些虽暂时无法纳入基本医保目录,但创新程度很高、临床应用价值显著的创新药品。分析人士认为,丙类目录或将优先考虑通过形式审查及专家评审但未被纳入基本医保目录的药品,国内创新药将有望打开支付空间。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02269"],"gpt_icon":0},{"id":"2504410137","title":"医药外包概念股集体走高 药明康德(02359)涨5.39% 瑞银看好近期CRO盈利前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2504410137","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504410137?lang=zh_cn&edition=full","pubTime":"2025-01-20 09:56","pubTimestamp":1737338200,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股集体走高，截至发稿，药明康德 涨5.39%，金斯瑞生物科技涨5.21%，药明生物涨4.90%，凯莱英涨3.65%，康龙化成涨3.31%。消息面上，中信建投发布研报称，医药改革进入深水区，高质量增长成为常态。医药领域的改革政策已进入常态化阶段，医保领域最值得关注的增量政策是建立多元复合的医保支付方式改革，医疗领域即将迎来薪酬制度及分级诊疗等“深水区”的改革。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1951746","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU1880383366.USD","LU2488822045.USD","02269","LU0043850808.USD","BK1161","BK1583","LU2242644610.SGD","06821","LU0039217434.USD","09939","LU1242518857.USD","LU0140636845.USD","LU2039709279.SGD","LU0819121731.USD","LU0456846285.SGD","BK1521","01548","603259","LU1046422090.SGD","HK0000306701.USD","03759","LU0456827905.SGD","LU0456842615.SGD","IE00B0JY6N72.USD","LU0348825331.USD","LU0326950275.SGD","HK0000320264.USD","LU0823426480.USD","LU1997245094.SGD","LU1242518931.SGD","BK0216","LU1688375341.USD","BK1141","159938","LU0348735423.USD","LU0359201612.USD","LU0856984785.SGD","BK1515","LU1720050803.USD","BK1610","LU0516423091.SGD","LU0051755006.USD","LU0320764599.SGD","LU0417516902.SGD","LU0516422440.USD","LU0516422952.EUR","BK1574","LU0572944931.SGD","02359"],"gpt_icon":0},{"id":"2504410962","title":"港股异动 | CRO概念股涨幅居前 医保丙类目录年内落地 国内创新药有望打开支付空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2504410962","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504410962?lang=zh_cn&edition=full","pubTime":"2025-01-20 09:53","pubTimestamp":1737338025,"startTime":"0","endTime":"0","summary":"招银国际指出，丙类目录或将优先考虑国谈中通过了形式审查及专家评审，却最终未被纳入基本医保目录的药品，例如CAR-T、ADC等，国内创新药有望打开支付空间。受益于国内CXO产业链的全面以及竞争力的领先，行业受地缘政治影响目前较为有限。近年来在ADC、多肽药物快速发展下，相关CXO需求迅速增加，小核酸、CGT等细分领域也有望迎来快速发展。长期来看，我们仍旧看好CXO板块发展潜力及成长空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0140636845.USD","LU1688375341.USD","LU0043850808.USD","LU0456827905.SGD","LU0572944931.SGD","LU0327786744.USD","LU0052750758.USD","06978","HK0000306701.USD","LU0039217434.USD","LU0181495838.USD","LU0516422366.SGD","LU0516422952.EUR","BK1574","LU0359202008.SGD","LU0516423091.SGD","LU0823426308.USD","159992","HK0000320264.USD","01548","03759","HK0000306685.HKD","HK0000320223.HKD","LU0516422440.USD","02269","LU1046422090.SGD","LU0708995583.HKD","LU2125910500.SGD","BK1161","IE00B0JY6N72.USD","LU0823426480.USD","02359","LU0348735423.USD","LU0417516902.SGD","LU0516423174.USD","LU0588546209.SGD","LU1242518857.USD","LU2039709279.SGD","LU1242518931.SGD","LU0856984785.SGD","LU0417516738.SGD","LU1880383366.USD","LU2045819591.USD","BK1589","BK1583","LU0326950275.SGD","LU0456846285.SGD","LU0819121731.USD","SG9999002562.SGD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2504101034","title":"港股医药股走强 药明生物涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504101034","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504101034?lang=zh_cn&edition=full","pubTime":"2025-01-20 09:44","pubTimestamp":1737337470,"startTime":"0","endTime":"0","summary":"每经AI快讯，港股医药股走强，截至发稿，药明生物(02269.HK)涨5.35%、药明康德(02359.HK)涨5.01%、泰格医药(03347.HK)涨2.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202501203301768734.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202501203301768734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999002562.SGD","LU0348735423.USD","LU0516423174.USD","LU0348825331.USD","LU1242518857.USD","BK1610","LU1880383366.USD","LU0417516902.SGD","BK1521","BK1589","LU1720050803.USD","LU0051755006.USD","LU0516422952.EUR","LU0708995583.HKD","SG9999002463.SGD","LU0456827905.SGD","LU0572944931.SGD","LU0856984785.SGD","LU1242518931.SGD","LU0327786744.USD","LU0819121731.USD","LU0516422366.SGD","LU0823426308.USD","LU0516422440.USD","BK1576","LU0140636845.USD","IE00B0JY6N72.USD","LU0181495838.USD","LU0307460666.USD","LU0320764599.SGD","LU0326950275.SGD","LU0516423091.SGD","02269","LU0039217434.USD","LU0588546209.SGD","LU0359201612.USD","BK1141","LU0043850808.USD","LU1794554557.SGD","LU0359202008.SGD","LU2039709279.SGD","LU0052750758.USD","LU0823426480.USD","LU1688375341.USD","LU0456846285.SGD","LU0417516738.SGD","LU0979878070.USD"],"gpt_icon":0},{"id":"2504176384","title":"药明生物(02269)上涨5.46%，报18.94元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2504176384","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504176384?lang=zh_cn&edition=full","pubTime":"2025-01-20 09:34","pubTimestamp":1737336880,"startTime":"0","endTime":"0","summary":"1月20日，药明生物(02269)盘中上涨5.46%，截至09:34，报18.94元/股，成交9874.67万元。药明生物技术有限公司是全球领先的生物制剂服务供应商，提供全面、综合及高度定制的服务，包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额，已与全球20大制药公司中的12家建立合作关系。截至2024年中报，药明生物营业总收入85.74亿元、净利润14.99亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/20093447596507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0456827905.SGD","LU0307460666.USD","LU0856984785.SGD","LU0417516902.SGD","SG9999002463.SGD","LU0359202008.SGD","LU0320764599.SGD","LU0516422952.EUR","LU0819121731.USD","BK1521","LU0979878070.USD","IE00B0JY6N72.USD","LU0348825331.USD","LU0588546209.SGD","LU0572944931.SGD","LU2039709279.SGD","LU1242518931.SGD","BK1141","LU0359201612.USD","LU0516422440.USD","LU0051755006.USD","LU0456846285.SGD","LU0823426308.USD","02269","LU1688375341.USD","LU0039217434.USD","LU0516423174.USD","BK1589","LU0043850808.USD","BK1576","LU0326950275.SGD","LU0708995583.HKD","LU0140636845.USD","BK1610","LU0823426480.USD","LU1720050803.USD","LU0327786744.USD","LU1880383366.USD","LU0348735423.USD","LU0052750758.USD","LU0417516738.SGD","LU1242518857.USD","SG9999002562.SGD","LU1794554557.SGD","LU0516422366.SGD","LU0181495838.USD","LU0516423091.SGD"],"gpt_icon":0},{"id":"2504940444","title":"药明生物盘中异动 早盘快速上涨5.01%报18.860港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504940444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504940444?lang=zh_cn&edition=full","pubTime":"2025-01-20 09:34","pubTimestamp":1737336862,"startTime":"0","endTime":"0","summary":"2025年01月20日早盘09时34分，药明生物股票出现异动，股价大幅上涨5.01%。截至发稿，该股报18.860港元/股，成交量470.594万股，换手率0.11%，振幅3.79%。药明生物股票所在的生物技术行业中，整体涨幅为0.63%。消息层面，截至09时34分，《药明生物：中金上调目标价至 22.5 港元》资讯为影响药明生物的重要信息。由于新签项目数量强劲增长，PPQ 项目储备丰富有望放量，中金上调 2024 至 2026 年经调整净利润，分别为 5.7%、6.2%及 22.4%，至 49.7、57.0 及 65.8 亿元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120093423986c192a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120093423986c192a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","LU0516423091.SGD","LU0052750758.USD","LU2039709279.SGD","LU1242518931.SGD","LU0039217434.USD","LU0819121731.USD","LU0348735423.USD","LU0140636845.USD","LU0359201612.USD","BK1610","02269","LU0516422952.EUR","LU0327786744.USD","LU1880383366.USD","LU0043850808.USD","LU0572944931.SGD","LU0417516902.SGD","LU1720050803.USD","LU0516422366.SGD","LU0456846285.SGD","LU1242518857.USD","LU0588546209.SGD","SG9999002463.SGD","LU0979878070.USD","IE00B0JY6N72.USD","LU0516423174.USD","LU0417516738.SGD","LU1688375341.USD","LU0516422440.USD","SG9999002562.SGD","BK1521","LU0326950275.SGD","LU0823426308.USD","LU0456827905.SGD","BK1141","LU1794554557.SGD","LU0708995583.HKD","LU0320764599.SGD","LU0823426480.USD","BK1589","LU0307460666.USD","LU0856984785.SGD","LU0181495838.USD","BK1576","LU0051755006.USD","LU0348825331.USD"],"gpt_icon":0},{"id":"2504545907","title":"【券商聚焦】招银国际升药明生物(02269)目标价5.9% 指积极的需求趋势为25年打下坚实基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2504545907","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504545907?lang=zh_cn&edition=full","pubTime":"2025-01-17 13:29","pubTimestamp":1737091778,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际发研报指，药明生物 在24年新签创纪录的151个新项目，且有权获得1.4亿美金的近期里程碑付款，此外海外运营稳步推进，预计爱尔兰生物药工厂将在25年产生利润。该行维持药明生物“买入”评级，上调目标价至24.24港元，以反映需求的复苏。该行预计药明生物2024E/25E/26E收入同比增长 7.1%/ 13.4%/ 15.6%，经调整归母净利润同比增长0.9%/ 13.0%/ 15.6%，对应现阶段股价的经调整PE分别为14.3x/ 12.7x/ 11.0x。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1951678","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"gpt_icon":0},{"id":"2504907187","title":"药明生物(02269)出现大手买入76.7万股，成交价$18.06，涉资1.385千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2504907187","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504907187?lang=zh_cn&edition=full","pubTime":"2025-01-17 13:25","pubTimestamp":1737091500,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在下午01:25出现大手买入，成交量为76.7万，成交价为港币$18.06，涉资1.385千万。至目前为止，股价升1.691%，今日最高价为$18.14，而最低价为$17.6，总成交量为2.52千万股，总成交金额港币$4.496亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2501174310/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1521","BK1610","SG9999002463.SGD","LU0823426480.USD","LU0052750758.USD","LU1794554557.SGD","LU0456827905.SGD","02269","LU0181495838.USD","LU0326950275.SGD","LU1688375341.USD","LU0140636845.USD","LU0516423091.SGD","LU1242518857.USD","LU0417516902.SGD","LU0039217434.USD","BK1576","LU0348825331.USD","LU0708995583.HKD","SG9999002562.SGD","LU0856984785.SGD","LU0588546209.SGD","LU0516423174.USD","LU1880383366.USD","LU0051755006.USD","IE00B0JY6N72.USD","LU0359201612.USD","LU0516422440.USD","LU0819121731.USD","LU1720050803.USD","LU0327786744.USD","LU2039709279.SGD","LU1242518931.SGD","LU0572944931.SGD","LU0359202008.SGD","LU0307460666.USD","LU0417516738.SGD","LU0043850808.USD","LU0516422366.SGD","BK1589","LU0456846285.SGD","LU0320764599.SGD","LU0516422952.EUR","BK1141","LU0348735423.USD","LU0823426308.USD","LU0979878070.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0341},{"period":"1month","weight":0.0693},{"period":"3month","weight":0.0795},{"period":"6month","weight":0.7073},{"period":"1year","weight":-0.3259},{"period":"ytd","weight":0.0364}],"compareEarnings":[{"period":"1week","weight":0.0461},{"period":"1month","weight":0.0196},{"period":"3month","weight":-0.0315},{"period":"6month","weight":0.1824},{"period":"1year","weight":0.3439},{"period":"ytd","weight":0.0023}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联（XDC）分部主要从事为抗体偶联药物（ADCs）及各种生物偶联药物提供合同研究、开发及生产组织（CRDMO）服务。该公司主要在国内和国外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.035805},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034807},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.00624},{"month":4,"riseRate":0.428571,"avgChangeRate":0.021731},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011574},{"month":6,"riseRate":0.571429,"avgChangeRate":0.069801},{"month":7,"riseRate":0.625,"avgChangeRate":0.059733},{"month":8,"riseRate":0.5,"avgChangeRate":0.030152},{"month":9,"riseRate":0.625,"avgChangeRate":0.034087},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023256},{"month":11,"riseRate":0.5,"avgChangeRate":0.046185},{"month":12,"riseRate":0.5,"avgChangeRate":0.009183}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}